Accesso libero

Trends in Pancreatic Cancer Mortality in Serbia: A Joinpoint Regression Analysis

, , , , , , , ,  e   
07 ago 2025
INFORMAZIONI SU QUESTO ARTICOLO

Cita
Scarica la copertina

Figure 1.

Trends of age-standardized pancreatic cancer mortality rates in Serbia by sex, in the period 2000–2021.
Trends of age-standardized pancreatic cancer mortality rates in Serbia by sex, in the period 2000–2021.

Figure 2.

Distribution of pancreatic cancer mortality by age groups in Serbia, 2000 – 2021.
Distribution of pancreatic cancer mortality by age groups in Serbia, 2000 – 2021.

Figure 3.

Trend in mortality of pancreatic cancer in Serbia, 2000 – 2021.
Trend in mortality of pancreatic cancer in Serbia, 2000 – 2021.

Number of death cases, crude rates and ASRs (per 100,000) for pancreatic cancer in Serbia, 2000 – 2021_

Year Total Men Women

N Crude rate ASRa N Crude rate ASRa N Crude rate ASRa
2000 747 9.94 5.30 401 10.97 6.48 346 8.96 4.28
2001 772 10.29 5.34 445 12.20 7.04 327 8.48 3.96
2002 835 11.13 5.72 466 12.78 7.22 369 9.58 4.49
2003 855 11.43 5.87 451 12.40 6.98 404 10.51 4.88
2004 852 11.42 5.70 476 13.12 7.32 376 9.81 4.29
2005 988 13.32 6.61 518 14.32 8.07 470 6.25 3.11
2006 910 12.28 6.11 520 14.43 7.99 390 10.24 4.54
2007 966 13.09 6.18 491 13.68 7.42 475 12.52 5.13
2008 1034 14.07 6.60 561 15.70 8.29 473 12.53 5.17
2009 1020 13.03 6.49 546 15.34 8.19 474 12.60 5.01
2010 1088 14.92 7.06 566 15.96 9.51 522 13.94 5.78
2011 1055 14.58 6.73 570 16.18 8.32 485 13.06 5.43
2012 1099 15.26 6.65 573 16.34 8.04 526 14.24 5.46
2013 1070 14.93 6.56 585 16.76 8.24 485 13.19 5.12
2014 1056 14.81 6.41 573 16.50 7.99 483 13.20 5.09
2015 1134 15.98 6.89 618 17.89 8.44 516 14.18 5.61
2016 1151 16.31 6.83 599 17.42 8.15 552 15.25 5.81
2017 1156 16.47 6.77 619 18.10 8.35 537 14.91 5.44
2018 1168 16.73 6.98 615 18.08 8.41 553 15.44 5.79
2019 1206 17.36 7.14 640 18.91 8.69 566 15.89 5.80
2020 1169 16.94 6.81 625 18.60 8.46 544 15.37 5.39
2021 1157 16.93 6.76 595 17.88 7.97 562 16.02 5.74

Overall 22488 14.15 6.43 12053 15.62 8.24 10435 12.55 5.06

Joinpoint regression analysis* of pancreatic cancer mortality by age in Serbia, 2000 – 2021_

Total Men Women

ASR±SD AAPCa (95% CIb) ASR±SD AAPCa (95% CIb) ASR±SD AAPCa (95% CIb)
25 – 29 0.2±0.2 0.1±0.2 0.2±0.3
30 – 34 0.3±0.3 0.3±0.4 0.3±0.5
35 – 39 0.4±0.4 −0.9 (−4.5–2.9) 1.2±0.7 0.3±0.5
40 – 44 2.1±0.6 −1.3 (−3.6–1.2) 3.1±1.5 −1.5 (−4.3–1.5) 1.4±0.7
45 – 49 5.01±1.2 0.4 (−1.4–2.4) 6.3±2.0 −0.5 (−2.5–1.6) 3.9±1.8 2.1 (−2.4–7.1)
50 – 54 10.4±1.2 0.1 (−0.8–0.9) 13.8±4.2 −0.1 (−1.9–1.7) 7.8±1.5 0.5 (−1.2–2.3)
55 – 59 18.7±2.1 0.1 (−0.8–1.1) 24.5±3.9 −0.7 (−1.9–0.5) 13.3±2.4 1.9* (0.6–3.2)
60 – 64 27.8±3.0 1.2* (0.5–1.8) 35.2±5.1 1.1* (0.1–2.2) 20.7±4.1 1.7 (−0.2–3.7)
65 – 69 40.0±5.5 1.7* (1.1–2.4) 50.6±7.4 1.* (1.0–2.5) 30.2±5.8 2.1* (0.6–3.7)
70 – 74 52.2±6.1 1.6* (0.6–2.6) 63.5±9.8 1.6* (0.6–2.6) 42.9±6.6 0.9* (0.01–1.8)
75 – 79 62.1±9.4 2.5* (1.2–3.7) 71.3±14.5 2.1* (0.6–3.6) 53.7±9.0 2.9* (0.3–3.6)
80 – 84 70.4±10.0 1.7* (0.7–2.8) 77.9±18.1 1.5 (−1.1–4.3) 65.2±12.2 2.1* (0.7–3.4)
85+ 63.3±11.4 3.1* (1.6–4.5) 68.2±22.9 57.9±13.3 4.4* (2.1–6.4)
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicina, Medicina clinica, Medicina clinica, altro